Tag:
pharmaceutical advertising
Latest Headlines
Latest Headlines
As blockbuster drugs fade, so does TV advertising
The DTC juggernaut is weakening. As The New York Times reports, industry spending on TV ads fell by 2% in 2011, the fourth consecutive year of decline. Altogether, TV spending is down 20% from 2007...
FDA weighs crackdown on 'distracting images' in DTC ads
In every pharmaceutical television commercial there's the bit at the end while a voiceover intones a litany of potential side effects anddrug warnings likely to startle anyone thinking of taking it.
Merck ($MRK) removes 'fast-acting relief' from allergy ads
After competitor complaints and U.K. regulatory action, Merck ( $MRK ) will remove its "fast-acting relief" claims from its Clarityn--sold in the U.S. as Claritin--allergy pills. Johnson & Johnson
Is pharma marketing ready for its digital close-up?
It might be time for drug marketers to abandon their TV-centric approach in favor of a real, live, well-thought-out digital strategy. As the blog KevinMD points out, plenty of new research shows that
Equal time for risk info in ads, FDA says
Increasingly, the FDA wants drugmakers to give equal billing to the possible risks of taking drugs, not just rattle them off in the last few seconds of a TV commercial or bury them deep in print.
Free e-book: Social media for Pharma
Social media is fraught with potential pitfalls for pharma brand managers. But, as the new FiercePharma e-book Social Media for Pharma Brand Managers points out, they needn't approach it with such
How will FDA enforce new DTC rules?
Newly proposed standards for DTC advertising were designed to give drug marketers flexibility in complying, the FDA says. But as some industry observers point out, the new rules would give FDA some
Franken backs repeal of DTC tax break
There's another lawmaker eyeing the tax deduction for drug advertising: Sen. Al Franken has introduced a bill ending that tax provision, saying that drugmakers should be focusing on development, not
